Nucleoporin TPR (translocated promoter region, nuclear basket protein) upregulation alters MTOR-HSF1 trails and suppresses autophagy induction in ependymoma

References

• Merchant TE. Current clinical challenges in childhood ependymoma: a focused review. J Clin Oncol. 2017;35(21):2364–2369.
   PubMed Web of Science ®Google Scholar
• Archer TC, Pomeroy SL. Defining the molecular landscape of ependymomas. Cancer Cell. 2015;27(5):613–615.
   PubMed Web of Science ®Google Scholar
• Witt H, Mack SC, Ryzhova M, et al. Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell. 2011;20(2):143–157.
   PubMed Web of Science ®Google Scholar
• Parker M, Mohankumar KM, Punchihewa C, et al. C11orf95-RELA fusions drive oncogenic NF-κB signaling in ependymoma. Nature. 2014;506(7489):451–455.
   PubMed Web of Science ®Google Scholar
• Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–820.
   PubMed Web of Science ®Google Scholar
• Archer TC, Pomeroy SL. Posterior fossa ependymomas: a tale of two subtypes. Cancer Cell. 2011;20(2):133–134.
   PubMed Web of Science ®Google Scholar
• Wu J, Armstrong TS, Gilbert MR. Biology and management of ependymomas. Neuro Oncol. 2016;18(7):902–913.
   PubMed Web of Science ®Google Scholar
• Karakoula K, Suarez-Merino B, Ward S, et al. Real-time quantitative PCR analysis of pediatric ependymomas identifies novel candidate genes including TPR at 1q25 and CHIBBY at 22q12-q13. Genes Chromosomes Cancer. 2008;47(11):1005–1022.
   PubMed Web of Science ®Google Scholar
• Mack SC, Pajtler KW, Chavez L, et al. Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling. Nature. 2018;553(7686):101–105.
   PubMed Web of Science ®Google Scholar
• Mohankumar KM, Currle DS, White E, et al. An in vivo screen identifies ependymoma oncogenes and tumor-suppressor genes. Nat Genet. 2015;47(8):878–887.
   PubMed Web of Science ®Google Scholar
• Modena P, Lualdi E, Facchinetti F, et al. Identification of tumour-specific molecular signatures in intracranial ependymomas and association with clinical characteristics. J Clin Oncol. 2006;24(33):5223–5233.
   PubMed Web of Science ®Google Scholar
• Phyllis F, Tinglu G, Cecilia S, et al. Tpr is localized within the nuclear basket of the pore complex and has a role in nuclear protein export. J Cell Biol. 2002;156(4):617–630.
   PubMed Web of Science ®Google Scholar
• Dewi FRP, Domoto T, Hazawa M, et al. Colorectal cancer cells require glycogen synthase kinase-3β for sustaining mitosis via translocated promoter region (TPR)-dynein interaction. Oncotarget. 2018;9(17):13337–13352.
   PubMedGoogle Scholar
• Hoelz A, Glavy JS, Beck M, et al. Toward the atomic structure of the nuclear pore complex: when top down meets bottom up. Nat Struct Mol Biol. 2016;23(7):624–630.
   PubMed Web of Science ®Google Scholar
• Raices M, D’Angelo MA. Nuclear pore complex composition: a new regulator of tissue-specific and developmental functions. Nat Rev Mol Cell Biol. 2012;13(11):687–699.
   PubMed Web of Science ®Google Scholar
• Wong RW. Nuclear pore complex: from structural view to chemical tools. Chem Biol. 2015;22(10):1285–1287.
   PubMedGoogle Scholar
• Kilday JP. Pediatric ependymoma: biological perspectives. Mol Cancer Res. 2009;7(6):765–786.
   PubMed Web of Science ®Google Scholar
• Su KH, Cao J, Tang Z, et al. HSF1 critically attunes proteotoxic-stress sensing by MTORC1 to combat stress and promote growth. Nat Cell Biol. 2016;18(5):527–539.
   PubMed Web of Science ®Google Scholar
• Guan S, Shen R, Lafortune T, et al. Establishment and characterization of clinically relevant models of ependymoma: a true challenge for targeted therapy. Neuro Oncol. 2011;13(7):748–758.
   PubMed Web of Science ®Google Scholar
• Milde T, Kleber S, Korshunov A, et al. A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat. Acta Neuropathol. 2011;122(5):637–650.
   PubMed Web of Science ®Google Scholar
• Yu L, Baxter PA, Voicu H, et al. A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo. Neuro Oncol. 2010;12(6):580–594.
   PubMed Web of Science ®Google Scholar
• Aizawa T, Hasegawa K, Ohkumo T, et al. Neural stem cell‐like gene expression in a mouse ependymoma cell line transformed by human BK polyomavirus. Cancer Sci. 2010;102(1):122–129.
   PubMed Web of Science ®Google Scholar
• Dong Y, Furuta T, Sabit H, et al. Identification of antipsychotic drug fluspirilene as a potential anti-glioma stem cell drug. Oncotarget. 2017;8(67):111728–111741.
   PubMedGoogle Scholar
• Funasaka T, Tsuka E, Wong RW. Regulation of autophagy by nucleoporin TPR. Sci Rep. 2012;8(1):878.
   Google Scholar
• Füllgrabe J, Klionsky DJ, Joseph B. The return of the nucleus: transcriptional and epigenetic control of autophagy. Nat Rev Mol Cell Biol. 2014;15(1):65–74.
   PubMed Web of Science ®Google Scholar
• Levy JMM, Towers CG, Thorburn A. Targeting autophagy in cancer. Nat Rev Cancer. 2017;17(9):528–542.
   PubMed Web of Science ®Google Scholar
• Skaggs HS, Xing H, Wilkerson DC, et al. HSF1-TPR interaction facilitates export of stress-induced HSP70 mRNA. J Bio Chem. 2007;282(47):33902–33907.
   PubMed Web of Science ®Google Scholar
• Dokladny K, Myers OB, Moseley PL. Heat shock response and autophagy - cooperation and control. Autophagy. 2015;11(2):200–213.
   PubMed Web of Science ®Google Scholar
• Chiang GG, Abraham RT. Phosphorylation of mammalian target of rapamycin (MTOR) at Ser-2448 is mediated by p70S6 kinase. J Biol Chem. 2005;280(27):25485–25490.
   PubMed Web of Science ®Google Scholar
• Chou SD, Prince T, Gong J, et al. MTOR is essential for the proteotoxic stress response, HSF1 activation and heat shock protein synthesis. PLoS One. 2012;7(6):e39679.
   PubMed Web of Science ®Google Scholar
• Gatica D, Lahiri V, Klionsky DJ. Cargo recognition and degradation by selective autophagy. Nat Cell Biol. 2018;20(3):233–242.
   PubMed Web of Science ®Google Scholar
• Park YE, Hayashi YK, Bonne G, et al. Autophagic degradation of nuclear components in mammalian cells. Autophagy. 2009;5(6):795–804.
   PubMed Web of Science ®Google Scholar
• Huang R, Xu Y, Wan W, et al. Deacetylation of nuclear LC3 drives autophagy initiation under starvation. Mol Cell. 2015;57(3):456–466.
   PubMed Web of Science ®Google Scholar
• Diao J, Liu R, Rong Y, et al. ATG14 promotes membrane tethering and fusion of autophagosomes to endolysosomes. Nature. 2015;520(7548):563–566.
   PubMed Web of Science ®Google Scholar
• Kobayashi A, Hashizume C, Dowaki T, et al. Therapeutic potential of mitotic interaction between the nucleoporin TPR and aurora kinase A. Cell Cycle. 2015;14(9):1447–1458.
   PubMed Web of Science ®Google Scholar
• Tabori U, Wong V, Ma J, et al. Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma. Br J Cancer. 2008;99(7):1129–1135.
   PubMed Web of Science ®Google Scholar
• Yuan Y. Molecular genetics of ependymoma. Chin J Cancer. 2011;30(10):669–681.
   PubMedGoogle Scholar
• Yorimitsu T, Klionsky DJ. Autophagy: molecular machinery for self-eating. Cell Death Differ. 2005;12(S2):1542–1552.
   PubMedGoogle Scholar
• Klionsky D, Abdelmohsen K, Abe A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016;12:1–222.
   PubMed Web of Science ®Google Scholar
• Han SH, Korm S, Han YG, et al. GCA links TRAF6-ULK1-dependent autophagy activation in resistant chronic myeloid leukemia. Autophagy. 2019;15(12):2076–2090.
   PubMed Web of Science ®Google Scholar
• Nazio F, Strappazzon F, Antonioli M, et al. MTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6. Nat Cell Biol. 2013;15(4):406–416.
   PubMed Web of Science ®Google Scholar
• Pankiv S, Clausen TH, Lamark T, et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem. 2007;282(33):24131–24145.
   PubMed Web of Science ®Google Scholar
• Mizushima N, Yoshimori T. How to interpret LC3 immunoblotting. Autophagy. 2007;3(6):542–545.
   PubMed Web of Science ®Google Scholar
• Nakano H, Funasaka T, Hashizume C, et al. Nucleoporin translocated promoter region (Tpr) associates with dynein complex, preventing chromosome lagging formation during mitosis. J Biol Chem. 2010;285(14):10841–10849.
   PubMed Web of Science ®Google Scholar
• Furuta T, Sabit H, Dong Y, et al. Biological basis and clinical study of glycogen synthase kinase- 3β-targeted therapy by drug repositioning for glioblastoma. Oncotarget. 2017;8(14):22811–22824.
   PubMedGoogle Scholar
• Arcella A, Biagioni F, Antonietta Oliva M, et al. Rapamycin inhibits the growth of glioblastoma. Brain Res. 2013;14958:37–51.
   PubMedGoogle Scholar